Description
Accelerate Preclinical Drug Development - Develop a Robust, Scalable Process from Preclinical to Clinical Development The NanoAssemblr® Ignite™ and Ignite+™ enable the controlled and precise assembly of lipid nanoparticles (LNPs) using NxGen™ microfluidic technology for preclinical studies. By modeling unit operations at scale and maintaining the same process parameters as the NanoAssemblr Blaze™ and GMP System, Ignite and Ignite+ simplify the transition into clinical development and manufacturing.
The Ignite platform of instruments is simple, easy-to-use and results in the automated synthesis of genomic medicines with minimal setup and training.
Features: - Reproducible - Reduce batch-to-batch and user variability with automated, advanced microfluidics
- Easy-to-Use - Formulate nanoparticles using a simple workflow with minimal setup and training
- Scalable - Predictably scale optimized formulations on the NanoAssemblr Blaze and GMP System
- Controlled Assembly - Tune critical quality attributes (CQAs) including particle size with precise control over fluid flow rates and ratios
- Minimized Risk - Model clinically relevant parameters and processes at small volumes
- Accelerated Timelines - Single-use technology, simple workflows and comprehensive support accelerate drug development